Citadel Advisors’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$226K Buy
28,800
+5,700
+25% +$41.4K ﹤0.01% 12029
2026
Q2
$150K Buy
23,100
+10,600
+85% +$50.8K ﹤0.01% 12350
2026
Q1
$40.6K Sell
12,500
-16,500
-57% -$63.6K ﹤0.01% 12485
2025
Q4
$115K Buy
29,000
+7,700
+36% +$22.8K ﹤0.01% 11524
2025
Q3
$66.5K Buy
+21,300
New +$70.8K ﹤0.01% 12063
2025
Q2
– Sell
-6,800
Closed -$28.8K – 12859
2025
Q1
$28.8K Buy
+6,800
New +$28.2K ﹤0.01% 12862
2024
Q3
– Sell
-200
Closed -$306 – 14337
2024
Q2
$306 Hold
200
– – ﹤0.01% 14036
2024
Q1
$336 Sell
200
-5,500
-96% -$11K ﹤0.01% 14359
2023
Q4
$9.9K Sell
5,700
-700
-11% -$1.28K ﹤0.01% 13133
2023
Q3
$12.1K Buy
6,400
+4,300
+205% +$7.21K ﹤0.01% 12980
2023
Q2
$3.09K Sell
2,100
-100
-5% -$173 ﹤0.01% 13722
2023
Q1
$4.29K Buy
+2,200
New +$5.23K ﹤0.01% 13966

Other funds holding CPIX

Citadel Advisors's CPIX Position: Q3 2026 in Review

Citadel Advisors reduced its Cumberland Pharmaceuticals (CPIX) stake by 14% in Q3 2026, selling an estimated $76.7K and leaving 62,817 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #10240.

Citadel Advisors first reported a position in CPIX in Q2 2013 and has held it in 20 quarters since. 35 funds tracked by Wall St. Rank hold CPIX as of Q3 2026.

  • Citadel Advisors held 62,817 shares of Cumberland Pharmaceuticals worth $492K as of Q3 2026.
  • Citadel Advisors sold 10,574 Cumberland Pharmaceuticals shares in Q3 2026, an estimated $76.7K.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #10240 holding.
  • Citadel Advisors first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 20 quarters since.
  • 35 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.